Thumbnail Image
Item

Putting GlaxoSmithKline to the test over paroxetine

Author
Doshi, Peter
Advisor
Date
2013-11-12
Embargo until
Language
Book title
Journal
Publisher
BMJ Publishing Group
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Collections
Dr. Peter Doshi
Show all metadata
Files
Thumbnail Image
Doshi_BMJ_GSK_paroxetine.pdf
Adobe PDF, 229.39 KB
Other Titles
See at
http://bmj.com/cgi/content/full/bmj.f6754?ijkey=daKgBqzhyNXwNUW&keytype=ref
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
Author discusses paroxetine, an antidepressant manufactured by GlaxoSmithKline, its use in adolescents, the controversy over Study 329, and the company's continued reticence to share all of its clinical trial data.
Series/Report No.
Sponsors
Rights/Terms
Citation
Doshi, P. (2013). Putting GlaxoSmithKline to the test over paroxetine. BMJ, 347. DOI: 10.1136/bmj.f6754
Keyword
research transparency
 Restoring Invisible and Abandoned Trials
 RIAT
 Study 329
 Access to Information
 Adolescent
 Clinical Trials as Topic
 Depression
 Paroxetine
 GlaxoSmithKline
Identifier to cite or link to this item
http://hdl.handle.net/10713/6614
Scopus Identifier
Embedded videos